COMP <GO>
BCPC vs FCX // GROSS PROFIT MARGIN
Balchem Corporation (NASDAQ) VS. Freeport-McMoRan Inc. (NYSE) • 15-METRIC TALLY: BCPC 7
— FCX 6
▲ GROSS PROFIT MARGIN LEADER: BCPC
LAST: $170.40 (+2.47%) • MKT CAP: $5.41B
gross-margins
35.70%
LAST: $66.14 (-0.69%) • MKT CAP: $94.98B
gross-margins
26.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BCPC VS. FCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BCPC | FCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 35.70% | 26.10% | +9.60 | BCPC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.00% | 21.50% | -7.50 | FCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.5x | 13.4x | +12.10 | FCX | /valuation <GO> |
| Free Cash Flow Yield | 4.00% | 4.71% | -0.71 | FCX | /fcf-yield <GO> |
| Operating Margin | 20.20% | 25.90% | -5.70 | FCX | /operating-margins <GO> |
| Net Profit Margin | 14.90% | 8.80% | +6.10 | BCPC | /net-margins <GO> |
| Revenue Growth (YoY) | 8.80% | 0.10% | +8.70 | BCPC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.52% | 0.91% | -0.39 | FCX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.67 | 3.08 | +6.59 | BCPC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | BCPC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.4 | 43.5 | +6.93 | BCPC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.95 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.6x | 40.1x | -7.50 | BCPC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.41B | $94.98B | -$89.56B | FCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BCPC REV | FCX REV | BCPC GROSS % | FCX GROSS % | BCPC FCF | FCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.04B | $25.19B | 35.7% | 26.1% | $216.6M | $4.48B |
| FY 2024 | $953.7M | $25.17B | 35.3% | 29.3% | $182.0M | $6.03B |
| FY 2023 | $922.4M | $22.70B | — | — | $183.8M | $4.26B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BCPC // BETA —
FCX // BETA 0.95